论文部分内容阅读
目的探讨慢性呼吸衰竭并发肺性脑病患者实施早期药物治疗的临床效果。方法选取我院在2009年7月到2012年6月收治的72例慢性呼吸衰竭并发肺性脑病患者的资料,将其按照随机分组的方法分为研究组和对照组各36例,两组患者均进行抗感染治疗,同时进行止咳化痰、平喘、吸痰、维持水电解质以及酸碱度平衡等治疗,研究组患者在此基础上进行早期药物治疗。比较两组患者的临床治疗效果。结果研究组患者有效率为94.44%,对照组患者有效率为69.44%,两组效果比较差异有统计学意义(P<0.05)。结论对慢性呼吸衰竭并发肺性脑病患者实施早期药物治疗可改善患者的临床症状,具有显著的治疗价值,值得推广。
Objective To investigate the clinical effect of early drug treatment in patients with chronic respiratory failure complicated with pulmonary encephalopathy. Methods The data of 72 patients with chronic respiratory failure complicated with pulmonary encephalopathy admitted in our hospital from July 2009 to June 2012 were divided into study group and control group according to the method of randomization. Each group of 36 patients All patients were treated with anti-infective therapy. At the same time, treatment of cough and phlegm, relieving asthma, suctioning sputum, maintaining water and electrolyte, and balancing pH with each other were conducted. Patients in the study group were treated on the basis of early drug treatment. The clinical effects of the two groups were compared. Results The effective rate of study group was 94.44%, while that of control group was 69.44%. The difference between the two groups was statistically significant (P <0.05). Conclusion Early treatment of patients with chronic respiratory failure and pulmonary encephalopathy can improve the clinical symptoms of patients with significant therapeutic value, which is worth promoting.